Related Experiment Video
Updated: Aug 12, 2026

A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome
Published on: October 2, 2018
Prolactin levels in the polycystic ovary syndrome
Abstract:
Plasma prolactin (PRL) was measured in 34 patients with polycystic ovary syndrome (PCO) before and after the intravenous administration of 200 micrograms of thyrotropin-releasing hormone (TRH). The results were compared with those from 30 normal female volunteers. The distinctive features of PCO were elevated plasma concentrations of luteinizing hormone (LH), testosterone and androstenedione and increased 24-hour urinary estrogen excretion. Abnormal secretion of PRL was observed in ten patients with PCO. Hyperprolactinemia was detected in five patients, and the prolactin response to TRH was exaggerated or prolonged in five normoprolactinemic patients with PCO. A statistically significant correlation was found between mean prolactin concentrations and the mean plasma dehydroepiandrosterone sulphate (DHEAS) concentration (r = 0.67, p less than 0.01). These data suggest that a significant portion of women with PCO syndrome have abnormalities of PRL secretion.
Related Concept Videos
Oogenesis
Hormonal Regulation of the Menstrual Cycle
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
Ovarian Cycle
Folliculogenesis
Hormonal Control of the Ovarian Cycle
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Cushing Syndrome II: Pathophysiology

